GCKR and metabolic dysfunction-associated steatotic liver disease: The major (P) allele of GCKR rs1260326 P446L (which reduces the risk of NAFLD) was associated with a modestly increased risk of T2D (OR 1.06, 95% c.i. 1.03–1.09).